Estradiol/estrone/estriol (brand name Hormonin) is a combination pharmaceutical medication produced by Shire which contains the estrogens estradiol (0.3 or 0.6 mg), estrone (0.7 or 1.4 mg), and estriol (0.135 or 0.27 mg) in a single oral tablet.[1][2][3][4]
| Combination of | |
|---|---|
| Estradiol | Estrogen |
| Estrone | Estrogen |
| Estriol | Estrogen |
| Clinical data | |
| Trade names | Hormonin |
| Routes of administration | By mouth[1][2][3][4] |
| Identifiers | |
| CAS Number | |
See also
editReferences
edit- ^ a b Krishna UR, Sheriar NK, Mandlekar A (1996). "Hormone Replacement Therapy". In Krisha UR, Shah D (eds.). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.
- ^ a b Buchsbaum HJ (6 December 2012). The Menopause. Springer Science & Business Media. pp. 60, 62–. ISBN 978-1-4612-5525-3.
- ^ a b Campbell G, Compston J, Crisp A (25 November 1993). The Management of Common Metabolic Bone Disorders. Cambridge University Press. pp. 48–. ISBN 978-0-521-43623-6.
- ^ a b Erkkola R (1 January 2006). The Menopause. Elsevier. pp. 264–. ISBN 978-0-444-51830-9.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |